Golden Triangle · Stream 2 · London

Biomarker Conference for Cambridge and Oxford Companies: London 2027

For Golden Triangle sequencing, proteomics, spatial and diagnostics companies: pre-scheduled 1:1 meetings with pharma biomarker teams in London on 3–4 March 2027, under an hour by train.

3–4 March 2027
London, UK
400+ target attendees
  • Cambridge and Oxford are about 50 minutes from London by train
  • Stream 2 sessions on multiplex, spatial, CDx and validation
  • London 2026 sponsors averaged 15–25 meetings each

Trusted by sponsors from our London 2026 launch edition

Miltenyi BiotecSeerCellCartaBioCytogenDigital ScienceGemPharmatechHawk Biosystems
Who sponsors ImmunoMark

Built for companies that sell to oncology R&D teams

Our London 2026 sponsors came from five kinds of company, and the Biomarkers & CDx stream adds a sixth. If yours is on this list, the agenda is built around your buyers.

Biomarker and lab services

Biomarker testing, flow cytometry and assay services for clinical trials.

Who you meet: Translational medicine and clinical biomarker leads

CellCarta

Preclinical models and discovery

In vivo models and antibody discovery for immuno-oncology pipelines.

Who you meet: Discovery, pharmacology and preclinical heads

BioCytogen GemPharmatech

Cell analysis and proteomics platforms

Instruments, reagents and platforms for immune profiling and proteomics.

Who you meet: Immune monitoring and translational science teams

Miltenyi Biotec Seer

Spatial biology and tissue analysis

Functional and spatial readouts from patient tissue.

Who you meet: Pathology and biomarker discovery leads

Hawk Biosystems

Research data and AI

Data, literature and analytics for R&D and competitive intelligence.

Who you meet: R&D strategy and data science teams

Digital Science

Diagnostics and CDx developers

The Biomarkers & CDx stream covers CDx development, regulatory strategy and market access.

Who you meet: Pharma CDx, regulatory and medical diagnostics leads

Stream 2: Biomarkers & Companion Diagnostics

Tell us which roles you need to meet and we will show you how the audience matches up.

Request the prospectus
Golden Triangle

A biomarker conference for Cambridge and Oxford companies, one train ride away

If your company sells sequencing, epigenetic, proteomic, spatial or diagnostic technology from Cambridge, Oxford, Stevenage or Harwell, the London edition of ImmunoMark Summit on 3–4 March 2027 puts pharma and biotech biomarker teams in front of you without a flight or a hotel block.

The 2nd annual UK edition expects 400+ delegates across two parallel streams: Stream 1, Next-Gen Immuno-Oncology, and Stream 2, Biomarkers & Companion Diagnostics. For most Golden Triangle tools and diagnostics companies, Stream 2 is where the buyers sit. The prospectus profiles them as Heads and Directors of Translational Medicine, Biomarker Operations Leads, Principal Scientists and teams in Biomarker Discovery & Development, Companion Diagnostics and Bioinformatics / Data Science.

300+delegates at London 2026
100+companies represented in 2026
70%senior decision-makers in 2026
15–25meetings per sponsor in 2026
Travel and staffing

Getting your team from the Golden Triangle to London

Every part of the cluster has a direct rail line into a London terminus, so you can staff a stand on day trips rather than overnight stays.

FromMain rail routeFastest timetabled journey
Cambridge (Cambridge or Cambridge North station)Great Northern to London King’s CrossAbout 50 minutes, with trains roughly every 20 minutes
Stevenage (Stevenage Bioscience Catalyst)Great Northern, Thameslink or LNER to London King’s CrossAbout 25 minutes
OxfordGWR to London PaddingtonAbout 52 minutes
OxfordChiltern Railways to London Marylebone1 hour 9 minutes fastest, 1 hour 26 minutes on average
Harwell CampusGWR from Didcot Parkway to London PaddingtonAbout 36 minutes

These are the fastest timetabled services. Average journeys run longer (Great Northern quotes about 1 hour 6 minutes on average from Cambridge), so add the hop across London from the terminus and check live times for your train.

  • Day 1 timing: breakfast networking opens at 08:00 and the chair’s welcome is at 08:50, so plan an early train. Day 1 closes at 18:15 with the drinks reception, which is worth staying for before a later train home.
  • Day 2 timing: the programme opens at 08:55 and closes with summit remarks at 16:30, so a team can be back in Cambridge or Oxford the same evening.
  • How many people: the Exhibitor package includes 2 team passes plus 2 client passes. Because travel is short, you can rotate people across the two days: application scientists on the stand on Day 1, a commercial lead for the 1:1 diary on Day 2.
  • Demo kit: a benchtop instrument or a set of posters and sample kits can travel by car or courier on the morning of Day 1, rather than by air freight. Confirm delivery arrangements with our team when you book.
The cluster

The Golden Triangle companies this page is written for

The region already supplies much of the technology a biomarker team buys. A few public examples show the range of segments, and the kind of company that fits Stream 2.

Sequencing and epigenetics

Illumina’s European headquarters is at Granta Park, south of Cambridge. Oxford Nanopore is headquartered at the Oxford Science Park and has a presence on Harwell Campus. biomodal, the former Cambridge Epigenetix, develops multiomic sequencing that reads genetic and epigenetic information from one sample, at Chesterford Research Park.

Proteomics, reagents and biomarker platforms

Abcam, now part of Danaher, runs its global headquarters from the Cambridge Biomedical Campus and describes itself as a proteomics company. At Babraham Research Campus, Tagomics is building a multiomic biomarker platform, and Novogene chose the campus for its first European genomic sequencing centre.

Diagnostics, CDx and CRO services

Dysplasia Diagnostics, at Babraham, works on RNA blood profiling for cancer. Domainex offers integrated drug discovery services from Chesterford Research Park.

Stevenage Bioscience Catalyst sits beside GSK and hosts the Cell and Gene Therapy Catapult, with a strong cell and gene therapy focus. Harwell Campus describes a growing health tech cluster around the Rosalind Franklin Institute and the MRC Harwell Institute. These companies are named as examples of the cluster’s segments, not as ImmunoMark sponsors or delegates.

Stream fit

Which stream fits a Cambridge or Oxford biomarker company

Sequencing, proteomics, spatial and diagnostics companies will usually choose Stream 2. Cell therapy analytics suppliers from the Stevenage side may also look at Stream 1. Each session below is quoted from the London 2027 agenda.

If your company sells…The London session that sets up the conversation
Sequencing, long-read or epigenetic assaysDay 2 · Stream 2: Keynote – Emerging Predictive & Prognostic Biomarkers in IO
Spatial biology and digital pathologyDay 1 · Stream 2: Digital Pathology & Spatial Transcriptomics in Oncology
Proteomics, antibody reagents and multiplex panelsDay 2 · Stream 2: Multiplex & Programmable Biomarker Platforms
Diagnostic tests and CDx developmentDay 2 · Stream 2: Companion Diagnostics Co-development Strategies; Panel: Global CDx Approval Pathways – EMA, FDA & MHRA Perspectives
Assay development and lab services (CRO)Day 1 · Stream 2: Biomarker Validation Strategies for Clinical Trial Success
Bioinformatics and biomarker data platformsDay 2 · Stream 2: Real-World Evidence Integration into Biomarker Strategy
Immune monitoring for cell therapy trialsDay 1 · Stream 1: Clinical Trial Design in Immunotherapy: Adaptive & Biomarker-Driven Models; Day 2 · Stream 2: Functional T cell Biomarkers for Precision Immuno-Oncology

The MHRA appears alongside the EMA and FDA in the Day 2 CDx panel, which matters to a UK diagnostics company planning a submission. For a deeper view of the CDx angle, see the companion diagnostics conference London page; discovery-stage spatial and single-cell vendors may prefer the oncology biomarker conference UK page.

Timing

Where 3–4 March sits in a Golden Triangle planning year

Year ends differ across the cluster, so check where early March falls in your own financial year. With a December year end, the event lands early in a new budget and the decision is usually made in the autumn plan. With a March year end, it falls in the closing weeks of the old budget, so it is worth agreeing which year carries the cost before you commit.

On the regional calendar, One Nucleus, the Cambridge-headquartered life sciences membership organisation, holds its Genesis conference in London on 10 December 2026. That is a natural point to finalise a first-quarter event plan, with ImmunoMark London following about twelve weeks later. Our Golden Triangle life sciences events guide lists the wider regional calendar, and the London biotech events guide covers the capital.

Packages

Which packages fit a regional tools or diagnostics company

Short travel means you can put more people in more meetings. Three packages cover most Golden Triangle companies.

Platinum (Stream 2)

For a platform company that wants stage time and a full meeting diary.

  • 10 pre-scheduled 1:1 meetings
  • 30-minute Day 1 talk plus Q&A
  • 10 x 6 ft booth
  • 8 + 8 passes

Exclusive 1:1 Meetings

For assay, CRO and lab-services teams who sell through technical conversations.

  • 3, 5, 7 or 10 meetings of 20 minutes
  • 2–4 passes plus drinks reception passes
  • Delegate list and wishlist

Exhibitor

For instrument and kit companies who want a stand for demos across both days.

  • 10 x 6 ft booth
  • 2 + 2 passes
  • Delegate list and wishlist

Headline, Gold, Silver and Branding packages are also available. Full contents are on the London sponsorship opportunities page, and the sponsorship ROI calculator lets you test each one against your own deal size. For how other sponsors used the format, read our case studies.

Tell us where your team is based and what you sell, and we will suggest the Stream 2 package that fits.

Request the prospectus
Sponsorship ROI calculator

What could London 2027 be worth to your team?

Pick a package, add your own numbers and see the pipeline it creates. London 2026 sponsors averaged 15 to 25 meetings each, with 70% senior decision-makers in the room.

1. Choose a package

Sponsorship packages
Exclusive 1:1 meeting packages

2. Your numbers

Year-one value of a new pharma or biotech customer

Booth visits, networking and questions after your talk

Share of conversations worth a proposal

Your typical close rate

Sponsorship plus travel and team costs

0x

Estimated return

expected first-year revenue for every £1 of your event budget

Pre-scheduled 1:1 meetings
Qualified conversations
New opportunities
Cost per conversation
Pipeline created
Expected revenue won

Get pricing and the prospectus for this package

Estimates only, based on the numbers you enter. Meetings and inclusions from the London 2027 sponsorship prospectus. 1:1 meetings are pre-scheduled with delegates you choose from the attendee list.

Email me this estimate

We will send your numbers to your inbox, ready to share with your team. Our sponsorship team gets a copy so they can answer questions.

    Sponsor case studies

    What sponsors get from ImmunoMark

    The real London 2026 results, plus profiles of how different types of company use the 1:1 meetings, talks and stand to build pipeline.

    What sponsors said

    Feedback from London 2026 sponsors

    Here is what sponsors told us at our London 2026 launch edition.

    We really liked the focus of the event, the topics, the talks, really good opportunity to engage with people, the support we get from you is really great and we appreciate that very much. Based on our experience we would be very interested in also sponsoring the next annual event.
    PromoCell GmbH logo
    Project Manager
    PromoCell GmbH · Sponsor, London 2026
    We are always interested in sponsoring interesting conference, based on this years experience, I guess I will manage to get some budget for the next edition.
    Secretech logo
    BD Manager Europe
    Secretech · Sponsor, London 2026
    Conversations I have had are very high level, the footfalls been great and the kind of research going on around is really life changing. We will be very interested in sponsoring the second annual.
    Miltenyi Biotec logo
    Research Account Manager
    Miltenyi Biotec · Sponsor, London 2026
    My experience here at Immunomark 2026 has been really great. We benefit from very good logistical organisation. Networking sessions were excellent and we consider Immunomark a strategic conference for the coming years.
    Rouken Bio logo
    Senior Business Development Director Europe
    Rouken Bio · Sponsor, London 2026
    We got the occasion to discuss customer projects and understand their needs better and how we can help them.
    Hologic Diagenode logo
    Epigenomics Applications Specialist
    Hologic Diagenode · Sponsor, London 2026
    The conference has been great so far with strong interactions at the booth and excellent attendance at our talk. We will definitely think about the next edition.
    Hologic Diagenode logo
    Biopharma Business Development Manager EMEA
    Hologic Diagenode · Sponsor, London 2026
    Quality of the talks were really nice and the attendee list had experts from biotech pharma field. It was great meeting everyone and we look forward to positive outcomes.
    HistologiX logo
    Business Development Executive
    HistologiX · Sponsor, London 2026
    The talks have been really interesting so far with a great combination of researchers and clinicians. Moderators encouraged excellent discussions.
    HAWK Biosystems logo
    Product Specialist
    HAWK Biosystems · Sponsor, London 2026

    Frequently asked questions

    Can our Cambridge or Oxford team do the London edition as day trips?

    Yes, for most teams. The fastest Great Northern trains from Cambridge to London King's Cross take about 50 minutes, GWR from Oxford to Paddington about 52 minutes, and Stevenage to King's Cross about 25 minutes. Day 1 opens with breakfast networking at 08:00 and ends with the drinks reception at 18:15; Day 2 closes at 16:30. Check live times for your train and allow for the journey across London.

    Which stream suits a Golden Triangle sequencing, proteomics or spatial company?

    Usually Stream 2, Biomarkers & Companion Diagnostics. Its London 2027 sessions include Digital Pathology & Spatial Transcriptomics in Oncology, Multiplex & Programmable Biomarker Platforms and Biomarker Validation Strategies for Clinical Trial Success. Cell therapy analytics suppliers may also look at Stream 1.

    Is there content for UK diagnostics companies thinking about MHRA as well as EMA and FDA?

    Yes. Day 2 of Stream 2 includes Panel: Global CDx Approval Pathways – EMA, FDA & MHRA Perspectives, followed later that afternoon by Companion Diagnostics Co-development Strategies.

    How many of our staff can come, and can we rotate people across the two days?

    Passes depend on the package: Platinum includes 8 team and 8 client passes, Gold 6 + 6, Silver 4 + 4 and Exhibitor 2 + 2. The Exclusive 1:1 Meetings package includes 2–4 passes plus drinks reception passes. Because the journey is short, many regional teams split the two days between application scientists and commercial staff; tell us your plan and we will confirm how passes can be used.

    How are the 1:1 meetings arranged?

    About 10 days before the event you receive the full delegate list with profiles, choose who you want to meet and flag priorities with the wishlist feature. Meetings are pre-scheduled 20-minute slots. Headline, Platinum and Gold include meetings, and the Exclusive 1:1 Meetings package offers 3, 5, 7 or 10.

    Sponsor ImmunoMark London 2027

    Tell us who you want to meet. We will send the prospectus and a package recommendation within one working day.